PAIN+ CPN

Mekhail N, Visnjevac O, Azer G, et al. Spinal Cord Stimulation 50 Years Later: Clinical Outcomes of Spinal Cord Stimulation Based on Randomized Clinical Trials-A Systematic Review. Reg Anesth Pain Med. 2018 May;43(4):391-406. doi: 10.1097/AAP.0000000000000744.
Ratings
Discipline Area Score
Physician 6 / 7
Rehab Clinician (OT/PT) 6 / 7
Abstract

To assess the efficacy of spinal cord stimulation (SCS) for each indication, one must critically assess each specific clinical outcome to identify outcomes that benefit from SCS therapy. To date, a comprehensive review of clinically relevant outcome-specific evidence regarding SCS has not been published. We aimed to assess all randomized controlled trials from the world literature for the purpose of evaluating the clinical outcome-specific efficacy of SCS for the following outcomes: perceived pain relief or change pain score, quality of life, functional status, psychological impact, analgesic medication utilization, patient satisfaction, and health care cost and utilization. Interventions were SCS, without limitation to the type of controls or the type of SCS in the active arms. For each study analyzed, a quality assessment was performed using a validated scale that assesses reporting, external validity, bias, confounding, and power. Each outcome was assessed specific to its indication, and the primary measure of each abovementioned outcome was a summary of the level of evidence. Twenty-one randomized controlled trials were analyzed (7 for trunk and limb pain, inclusive of failed back surgery syndrome; 8 for refractory angina pectoris; 1 for cardiac X syndrome; 3 for critical limb ischemia; 2 for complex regional pain syndrome; and 2 for painful diabetic neuropathy). Evidence assessments for each outcome for each indication were depicted in tabular format. Outcome-specific evidence scores were established for each of the abovementioned indications, providing both physicians and patients with a summary of evidence to assist in choosing the optimal evidence-based intervention. The evidence presented herein has broad applicability as it encompasses a breadth of patient populations, variations of SCS therapy, and comparable controls that, together, reflect comprehensive clinical decision making.

Comments from MORE raters

Physician rater

This study is not directly relevant to neurologists (I have never referred anyone for a spinal cord stimulator). It's a complex area. Many of these syndromes have a strong functional component where it could be argued further invasive medical intervention should be avoided and psychological/rehab therapy is preferred. Long-term outcome is crucial but it was difficult to find data on follow-up duration in included trials as it was for sample sizes and I could not see any data on adverse events.

Rehab Clinician (OT/PT) rater

While this article on the efficacy of spinal stimulation pain is not directly relevant to the daily treatments of OTs, it is useful to be aware that this modality can be of use to patients with chronic pain.
Comments from PAIN+ CPN subscribers

No subscriber has commented on this article yet.